Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 09, 2019; 92 (15 Supplement) May 6, 2019

Electronic Fetal Monitoring as a Remedy for Cerebral Palsy in Africa: First Do No Harm (P2.6-049)

James C. Johnston, Thomas P. Sartwelle, Berna Arda, Mehila Zebenigus
First published April 16, 2019,
James C. Johnston
1Global Neurology San Antonio TX United States
2Neurology, Addis Ababa University Addis Ababa Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas P. Sartwelle
3Hicks Davis Wynn Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berna Arda
4Medical Ethics, Ankara University Ankara Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehila Zebenigus
2Neurology, Addis Ababa University Addis Ababa Ethiopia
5Yehuleshet Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Electronic Fetal Monitoring as a Remedy for Cerebral Palsy in Africa: First Do No Harm (P2.6-049)
James C. Johnston, Thomas P. Sartwelle, Berna Arda, Mehila Zebenigus
Neurology Apr 2019, 92 (15 Supplement) P2.6-049;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To evaluate the use of electronic fetal monitoring (EFM) as a means of reducing cerebral palsy (CP) in sub-Saharan Africa (SSA).

Background: CP is a significant problem in SSA where it is characteristically albeit erroneously considered synonymous with birth asphyxia, leading to the increasing use of EFM in a misguided effort to reduce perinatal morbidity and mortality.

Design/Methods: We performed a systematic literature review of relevant publications since EFM’s inception a half-century ago (PUBMED, SCOPUS and COCHRANE), and surveyed neurologists, paediatricians and obstetricians in the East African region.

Results: EFM has a 99.8% false positive rate, does not predict or prevent CP or any other neonatal neurological injury and has no proven efficacy in routine childbirth. EFM causes significant harm to mothers and babies by prompting unnecessary C-sections with all of the attendant complications of that procedure, leading to considerable risks in subsequent pregnancies including lifelong repeat C-sections with high rates of operative complications, uterine rupture, and placental abnormalities, all having a higher morbidity and mortality in SSA. Recent evidence suggests babies born by C-sections suffer an increased risk of chronic and autoimmune diseases. Additionally, while EFM use without informed consent is unethical, it may be challenging to obtain true informed consent in the SSA population.

Conclusions: EFM is a waste of extremely scarce resources while simultaneously adding another layer of useless staff training complexity as well as significant morbidity and mortality to a desperately critical situation. The authors recommend ending continuous EFM in routine pregnancies in SSA, which aligns with the Australian, Canadian, New Zealand and United Kingdom guidelines, follows recent USA recommendations, and comports with the World Health Organization Quality of Care Network goals. EFM related funding should be redirected to improve healthcare for mothers, train birth attendants, and focus on therapeutic intervention for children with CP and related neurological disorders.

Disclosure: Dr. Johnston has nothing to disclose. Dr. Sartwelle has nothing to disclose. Dr. Arda has nothing to disclose. Dr. Zebenigus has nothing to disclose.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials

Dr. Nicole Sur and Dr. Mausaminben Hathidara

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (23)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise